KROS logo

Keros Therapeutics, Inc. (KROS)

Profile

Full Name

Keros Therapeutics, Inc.

Ticker

NASDAQ: KROS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 8, 2020

Indexes

Not included

Website

https://www.kerostx.com

Employees

163

Key Details

Price

$15.90(+0.63%)

Market cap

$645.78M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.55M(+2250.99% YoY)

Annual EPS

-$5.00(+3.85% YoY)

PE ratio

51.29

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $15.90
    KROS price is $15.90

    30-Day Relative Volume

    0.57
    KROS 30-day relative volume is 0.57

    Price Performance

    Price Today change

    +0.63%
    KROS price is up +0.63% today

    Price YTD change

    +0.44%
    KROS price is up +0.44% since January 1st

    Price 1-year change

    -71.11%
    KROS price is down -71.11% year-on-year

    Price 3-year change

    -56.75%
    KROS price is down -56.75% over the past 3 years

    Price Range

    Price All-time high

    $88.80
    KROS price is currently -82.09% below its historical high of $88.80

    Price 3-year low

    $9.12
    KROS price is currently +74.34% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $645.78M
    KROS market capitalization is $645.78 million

    Market cap 3-year change

    -31.79%
    KROS market capitalization is down -31.79% over the past 3 years

    Market cap All-time high

    $2.84B
    KROS market capitalization is currently -77.23% below its historical high of $2.84 billion

    Market cap sector rank

    66.69%
    KROS market capitalization is higher than 66.69% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +8.24%
    KROS shares outstanding is up +8.24% year-on-year

    Shares Outstanding 3-Year Change

    +57.69%
    KROS shares outstanding is up +57.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.38
    KROS beta is 0.38

    200-day SMA

    $16.21
    KROS price is currently -1.93% below its 200-day simple moving average

    50-day SMA

    $14.67
    KROS price is currently +8.35% above its 50-day simple moving average

    RSI

    60.68
    KROS 14-day relative strength index is 60.68

    Volume

    0.57
    KROS 30-day relative volume is 0.57

    ATR

    $0.51
    KROS average true range is $0.51

    10-day Historical Volatility

    15.85%
    KROS 10-day historical volatility is 15.85%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.55M
    KROS annual revenue is $3.55 million

    Revenue Analysts estimate

    $235.19M
    KROS annual revenue is currently -98.49% lower than the consensus analysts' forecast

    Revenue 1-year change

    +2250.99%
    KROS annual revenue is up +2250.99% year-on-year

    Revenue Sector rank

    41.93%
    KROS annual revenue is higher than 41.93% of companies in Healthcare sector

    EPS

    EPS

    -$5.00
    KROS annual earnings per share is -$5.00

    EPS Analysts estimate

    $1.00
    KROS annual earnings per share is currently -601.91% lower than the consensus analysts' forecast

    EPS 1-year change

    +3.85%
    KROS annual earnings per share is up +3.85% year-on-year

    EPS Sector rank

    19.73%
    KROS annual earnings per share is higher than 19.73% of companies in Healthcare sector

    Profit

    Gross profit

    $2.32M
    KROS annual gross profit is $2.32 million

    Gross margin

    65.38%
    KROS annual gross profit margin is 65.38%

    Operating profit

    -$209.59M
    KROS annual operating income is -$209.59 million

    Operating margin

    -5938.96%
    KROS annual operating profit margin is -5938.96%

    Net income

    -$187.35M
    KROS annual net profit is -$187.35 million

    Net margin

    -5277.55%
    KROS annual net profit margin is -5277.55%

    Expenses

    Total expenses

    $213.15M
    KROS annual total expenses is $213.15 million

    Operating expenses

    $213.15M
    KROS annual total operating expenses is $213.15 million

    Cost of goods sold

    $1.23M
    KROS annual cost of goods sold is $1.23 million

    Selling, general & administrative expenses

    $40.75M
    KROS annual SGA is $40.75 million

    Depreciation and amortization

    $1.23M
    KROS annual depreciation & amortization is $1.23 million

    Interest expense

    $0.00
    KROS annual interest expense is $0.00

    Income tax

    $300.00K
    KROS annual income tax is $300.00 thousand

    EBIT & EBITDA

    EBIT

    -$187.05M
    KROS annual earnings before interest & taxes is -$187.05 million

    EBITDA

    -$185.82M
    KROS annual EBITDA is -$185.82 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $615.89M
    KROS annual total assets is $615.89 million

    Non current assets

    $26.99M
    KROS annual long term assets is $26.99 million

    Current assets

    $588.89M
    KROS annual total current assets is $588.89 million

    Cash and cash equivalents

    $559.93M
    KROS annual cash & cash equivalents is $559.93 million

    Accounts receivable

    $2.74M
    KROS annual accounts receivable is $2.74 million

    Inventory

    $0.00
    KROS annual inventory is $0.00

    Liabilities

    Total liabilities

    $44.33M
    KROS annual total liabilities is $44.33 million

    Long term liabilities

    $16.88M
    KROS annual total long term liabilities is $16.88 million

    Current liabilities

    $27.45M
    KROS annual total current liabilities is $27.45 million

    Accounts payable

    $4.60M
    KROS annual accounts payable is $4.60 million

    Debt

    Total debt

    $18.86M
    KROS annual total debt is $18.86 million

    Total debt 1-year change

    +30.58%
    KROS annual total debt is up +30.58% year-on-year

    Long term debt

    $16.88M
    KROS annual long term debt is $16.88 million

    Short term debt

    $1.98M
    KROS annual short term debt is $1.98 million

    Equity & Capital

    Shareholders equity

    $571.55M
    KROS annual stockholders equity is $571.55 million

    Book value

    $571.55M
    KROS annual book value is $571.55 million

    Retained earnings

    -$568.78M
    KROS annual retained earnings is -$568.78 million

    Working capital

    $561.44M
    KROS annual working capital is $561.44 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$160.87M
    KROS annual cash flow from operations is -$160.87 million

    Cash from operations 1-year change

    -29.2%
    KROS annual cash flow from operations is down -29.2% year-on-year

    Cash from investing

    -$1.93M
    KROS annual cash flow from investing activities is -$1.93 million

    Cash from investing 1-year change

    +21.63%
    KROS annual cash flow from investing activities is up +21.63% year-on-year

    Cash from financing

    $391.82M
    KROS annual cash flow from financing activities is $391.82 million

    Cash from financing 1-year change

    +118.95%
    KROS annual cash flow from financing activities is up +118.95% year-on-year

    CAPEX

    CAPEX

    $1.93M
    KROS annual capital expenditures is $1.93 million

    CAPEX 1-year change

    -21.63%
    KROS annual capital expenditures is down -21.63% year-on-year

    Free Cash Flow

    Free cash flow

    -$162.80M
    KROS annual free cash flow is -$162.80 million

    Free cash flow 1-year change

    -28.22%
    KROS annual free cash flow is down -28.22% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    65.38%
    KROS annual gross profit margin is 65.38%

    Operating margin

    -5938.96%
    KROS annual operating profit margin is -5938.96%

    Net margin

    -5277.55%
    KROS annual net profit margin is -5277.55%

    ROA & ROE

    ROA

    -38.01%
    KROS annual return on assets is -38.01%

    ROE

    -41.46%
    KROS annual return on equity is -41.46%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    51.29
    KROS price to earnings ratio is 51.29

    PE ratio Sector rank

    79.15%
    KROS price to earnings ratio is higher than 79.15% of companies in Healthcare sector

    PB Ratio

    PB ratio

    0.91
    KROS price to book ratio is 0.91

    PB ratio Sector rank

    32.21%
    KROS price to book ratio is higher than 32.21% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.77
    KROS price to sales ratio is 2.77

    PS ratio Sector rank

    43.32%
    KROS price to sales ratio is higher than 43.32% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$26.48M
    KROS enterprise value is -$26.48 million

    Enterprise value Sector rank

    3.64%
    KROS enterprise value is higher than 3.64% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.04
    KROS EV/EBITDA is -1.04

    EV/EBITDA Sector rank

    46.82%
    KROS EV/EBITDA is higher than 46.82% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    21.45
    KROS annual current ratio is 21.45

    Quick ratio

    21.45
    KROS annual quick ratio is 21.45

    Leverage

    Debt to equity

    0.00
    KROS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    KROS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    7
    KROS piotroski f-score is 7

    Altman Z-Score

    7.54
    KROS altman z-score is 7.54

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 HC Wainwright & Co.
    Buy
    Jun 10, 25 B of A Securities
    Neutral
    May 30, 25 Wedbush
    Neutral
    May 12, 25 Scotiabank
    Sector Outperform
    May 8, 25 HC Wainwright & Co.
    Buy
    Apr 9, 25 Truist Securities
    Buy
    Apr 1, 25 Wedbush
    Neutral
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Feb 27, 25 Wells Fargo
    Overweight
    Feb 27, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with KROS included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Keros Therapeutics, Inc.?
    • Does Keros Therapeutics, Inc. pay dividends?
    • What sector is Keros Therapeutics, Inc. in?
    • What industry is Keros Therapeutics, Inc. in?
    • What country is Keros Therapeutics, Inc. based in?
    • When did Keros Therapeutics, Inc. go public?
    • Is Keros Therapeutics, Inc. in the S&P 500?
    • Is Keros Therapeutics, Inc. in the NASDAQ 100?
    • Is Keros Therapeutics, Inc. in the Dow Jones?
    • When was Keros Therapeutics, Inc.'s last earnings report?
    • When does Keros Therapeutics, Inc. report earnings?

    What is the ticker symbol for Keros Therapeutics, Inc.?

    The ticker symbol for Keros Therapeutics, Inc. is NASDAQ:KROS

    Does Keros Therapeutics, Inc. pay dividends?

    No, Keros Therapeutics, Inc. does not pay dividends

    What sector is Keros Therapeutics, Inc. in?

    Keros Therapeutics, Inc. is in the Healthcare sector

    What industry is Keros Therapeutics, Inc. in?

    Keros Therapeutics, Inc. is in the Biotechnology industry

    What country is Keros Therapeutics, Inc. based in?

    Keros Therapeutics, Inc. is headquartered in United States

    When did Keros Therapeutics, Inc. go public?

    Keros Therapeutics, Inc.'s initial public offering (IPO) was on April 8, 2020

    Is Keros Therapeutics, Inc. in the S&P 500?

    No, Keros Therapeutics, Inc. is not included in the S&P 500 index

    Is Keros Therapeutics, Inc. in the NASDAQ 100?

    No, Keros Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Keros Therapeutics, Inc. in the Dow Jones?

    No, Keros Therapeutics, Inc. is not included in the Dow Jones index

    When was Keros Therapeutics, Inc.'s last earnings report?

    Keros Therapeutics, Inc.'s most recent earnings report was on May 7, 2025

    When does Keros Therapeutics, Inc. report earnings?

    The next expected earnings date for Keros Therapeutics, Inc. is November 5, 2025
    On this page